Research summary
Pulmonary pathology classification and clinical guidelines for interstitial lung disease and pulmonary nodule management organize this research output. A 2013 American Journal of Respiratory and Critical Care Medicine official ATS/ERS statement updated the 2002 international multidisciplinary classification of idiopathic interstitial pneumonias (IIPs), originally defining seven specific entities with standardized terminology and diagnostic criteria and replacing histologic gold-standard diagnosis with multidisciplinary approach; the 2013 update incorporated publications through 2011 to refine the seven entities [1]. A 2018 AJRCCM official ATS/ERS/JRS/ALAT clinical-practice guideline updated the diagnostic criteria for idiopathic pulmonary fibrosis, with evidence synthesis and recommendation grading via the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach by an international multidisciplinary committee [2]. A 1992 Annals of Internal Medicine analysis prospectively studied 158 of 180 Wegener granulomatosis patients referred to NIAID over 24 years (followed 6 months to 24 years; 1,229 patient-years), recording clinical-presentation characteristics, surgical pathology, course of illness, laboratory and radiographic findings, and medical/surgical treatment results in a computer-based information-retrieval system at the Warren Magnuson Clinical Center [3]. A 2017 Radiology paper from the Fleischner Society provided updated guidelines for managing incidental pulmonary nodules detected on CT, with corresponding online supplemental material [4]. The cited works share a methodological emphasis on multidisciplinary international consensus, multi-society guideline development, systematic literature review with evidence grading, and longitudinal cohort follow-up to establish diagnostic and management standards across the spectrum of diffuse parenchymal lung diseases and pulmonary-nodule surveillance.
Recent publications
- International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung AdenocarcinomaDOI
- The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung CancerDOI
- The 2015 World Health Organization Classification of Lung TumorsDOI
- An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial PneumoniasDOI
- Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice GuidelineDOI
- Wegener Granulomatosis: An Analysis of 158 PatientsDOI
- Somatic mutations affect key pathways in lung adenocarcinomaDOI
- Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017DOI
- Comprehensive genomic profiles of small cell lung cancerDOI
- Pathology and genetics of tumours of the lung , pleura, thymus and heart
The lab page does not clearly state student acceptance status. Email the professor directly to confirm.
How to apply
Email William D. Travis 6-12 months before your application deadline. Read several recent papers and reference specific work in your message. Use our how to email a Japanese professor guide for the proven email structure.
For applications via MEXT scholarship: see our MEXT 2027 complete guide and university-specific University Recommendation track.
External profiles
- ORCID: https://orcid.org/0000-0003-3160-6729
- OpenAlex: openalex.org
Profile compiled from public sources (Researchmap, OpenAlex, University of Tsukuba faculty directory). Last refreshed 2026-05. Report incorrect information.